Functionalized nucleic acid probe, electrochemical biosensor, preparation method and application
By using carbonized Fe-CCOF material and nucleic acid complex combined with methylene blue-labeled COF material in electrochemical biosensors, ratio-type electrochemical biosensors are constructed, which solves the problem of insufficient complexity and sensitivity of detecting antibiotic residues in the prior art, and achieves the realization of High sensitivity and stability, suitable for rapid detection.
Patent Information
- Application Number
- CN202410930046.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-05
AI Technical Summary
Existing nanomaterial-based electrochemical biosensors have complex operational complexity, high cost, insufficient sensitivity and accuracy when detecting antibiotic residues in foods, and are susceptible to environmental and instrumental interference.
Using carbonized Fe-CCOF material as the substrate, the nucleic acid complex is solidified on its surface through Au-S bond, and the specific binding of biotin in the nucleic acid complex and streptavidin is used to label methylene blue COF material. The ratio-type electrochemical biosensor is constructed on the surface of nucleic acid functionalized Fe-CCOF, and the concentration of the substance to be measured is calculated using the signal ratio of methylene blue and internal reference substances to eliminate interference factors.
It achieves high sensitivity, accuracy and stability, breaks through the limitations of traditional electrochemical biosensors, has anti-interference ability, is suitable for rapid detection, and does not require expensive large-scale equipment.
Smart Images

Figure CN118895271A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of sensor technology, and in particular to a functionalized nucleic acid probe, an electrochemical biosensor, and a preparation method and application thereof. Background Art
[0002] Kanamycin (Kana) is an aminoglycoside antibiotic that mainly interferes with the protein synthesis of pathogens by binding to the corresponding position of the pathogen ribosome, thereby playing an antibacterial role. Because it can effectively inhibit Gram-negative bacteria, it is mainly used in the clinic to treat infectious diseases caused by sensitive bacteria. Due to its low price and good antibacterial effect, kanamycin is often used as a veterinary drug for animal breeding in animal husbandry. However, excessive use of kanamycin will cause the drug to remain deposited in animal-derived foods, which may eventually accumulate in the human body through the food chain, posing a potential hazard to human health. Long-term use of foods containing excessive kanamycin can cause a variety of harmful side effects such as ototoxicity, nephrotoxicity and neurotoxicity. Therefore, in order to strengthen the supervision and control of kanamycin residues in animal-derived foods, it is necessary to develop a method for the quantitative detection of kanamycin with high sensitivity, low cost and accuracy.
[0003] In recent years, many technologies have been used for sensitive analysis of antibiotic residues, including high performance liquid chromatography, surface plasmon resonance spectroscopy, phosphors, capillary electrophoresis and colorimetry. However, these technologies are complex to operate and require the use of expensive and bulky instruments, which are not suitable for rapid on-site detection applications. Electrochemical analysis technology has the advantages of easy use, miniaturization of instruments, low cost, rapid diagnosis and detection, and has aroused great interest. In recent years, due to the development and application of specific nucleic acid aptamers, highly specific and highly sensitive biosensors based on nucleic acid probes have attracted widespread attention. Since nucleic acid aptamers have flexible design and are easy to combine with nucleic acid amplification technology, some methods for detecting antibiotic residues in food using electrochemical aptamer sensors enhanced by nucleic acid amplification technology have emerged.
[0004] Nanomaterials can not only provide a powerful platform for the fixation of aptamers on the electrode surface, but also significantly improve the conductivity, active surface area or catalytic activity of the electrode, thereby achieving the amplification of the electrical signal response. However, the existing methods of detecting biological residues based on nanomaterial-sensitized electrochemical biosensors still face the following challenges: (1) In order to make nanomaterials have good electrochemical activity, multiple nanomaterials are usually required to be combined, which not only leads to cumbersome steps and high costs, but also increases the density of the material, resulting in limited electrochemical activity and insufficient signal amplification ability; (2) Most methods are easily affected by interference factors such as the environment, instrument or electrode surface state, resulting in reduced analytical performance such as sensor accuracy, specificity and stability. Therefore, designing electrode materials with excellent conductivity, active surface area and catalytic activity, as well as their corresponding electrochemical biosensors, so as to effectively improve the sensitivity and accuracy of antimicrobial residue detection, is an important issue that needs to be urgently addressed in the current analysis of trace antibiotic residues in food. Summary of the invention
[0005] In view of the problems that existing methods for detecting antibiotics in food are complicated in operation and require expensive instruments, and the detection sensitivity and accuracy of electrochemical biosensors need to be further improved, the present invention provides a functionalized nucleic acid probe, an electrochemical biosensor, and a preparation method and application.
[0006] In order to achieve the above-mentioned object of the invention, the embodiment of the present invention adopts the following technical solution:
[0007] A functionalized nucleic acid probe comprises a nucleic acid functionalized Fe-CCOF material and a signal-labeled COF material specifically bound to the nucleic acid functionalized Fe-CCOF material via streptavidin-biotin;
[0008] The nucleic acid functionalized Fe-CCOF material comprises a Fe-CCOF material and a nucleic acid complex chemically bonded to the surface of the Fe-CCOF material through an Au-S bond; the nucleic acid complex comprises a DNA tetrahedron and a biotin-modified nucleic acid aptamer connected to a vertex of the DNA tetrahedron and matching the object to be detected;
[0009] The signal-labeled COF material comprises a COF material, methylene blue loaded on the surface of the COF material, and streptavidin chemically bonded to the surface of the COF material through an amide bond;
[0010] The Fe-CCOF material is prepared by carbonizing an amino-containing monomer, an aldehyde-containing monomer, and a monomer containing Fe and an aldehyde group through a condensation reaction.
[0011] Compared with the prior art, the present invention uses a carbonized Fe-CCOF material with excellent conductivity, high specific surface area and high catalytic activity as a substrate, immobilizes a nucleic acid complex on the surface of the carbonized Fe-CCOF through an Au-S chemical bond, and utilizes the specific binding of biotin in the nucleic acid complex with streptavidin to immobilize a COF material labeled with methylene blue on the surface of the nucleic acid functionalized Fe-CCOF. When the sample to be tested is tested, the nucleic acid aptamer in the nucleic acid complex forms a nucleic acid aptamer-signal labeled COF material-target complex with the sample to be tested, and is separated from the tetrahedral DNA, thereby causing the signal intensity of the methylene blue to weaken. At the same time, the remaining Fe-CCOF material has excellent electrocatalytic performance. Therefore, a substance that can effectively catalyze oxidation can be selected as an internal reference substance, and the concentration of the substance to be tested can be calculated using the signal ratio of methylene blue and the internal reference substance, so as to eliminate the influence of interference factors such as the environment, instrument or electrode surface state, thereby improving the accuracy and sensitivity of the detection.
[0012] On one hand, the present invention uses carbonized Fe-CCOF material as a substrate for loading nucleic acid aptamers, and utilizes its excellent electrocatalytic activity to electrocatalyze the internal reference substance as a signal output unit; on the other hand, COF material is loaded with a large amount of methylene blue signal molecules to construct an electrochemical label for signal enrichment and amplification, and the electrocatalysis of methylene blue by COF material is used as another signal output unit, and the ratio of the two signal units is used to construct a ratio electrochemical biosensor. In the prior art, most ratio electrochemical biosensors for detecting antibiotics require the nucleic acid probe to be labeled with a signal molecule (such as methylene blue or ferrocene, etc.), and this labeling will reduce the binding force between the nucleic acid probe and the target molecule. At the same time, most of them are 1:1 labeling of the nucleic acid probe and the signal analysis, resulting in insufficient sensitivity of the electrochemical biosensor. The present invention adopts two COF-based nanomaterials to load nucleic acid aptamers and signal molecules respectively, and utilizes the specific action of streptavidin and biotin to combine the COF-based materials loaded with two functional substances, thereby effectively improving the binding affinity of the two materials, thereby effectively improving the stability of the probe, and quantitatively calculating the concentration of the substance to be detected through the dual signal ratio, thereby improving the signal-to-noise ratio, and enhancing the sensitivity and detection range of the device.
[0013] The label-free ratiometric electrochemical biosensor provided by the present invention has the advantages of stable signal and strong anti-matrix interference ability, effectively improves the stability of the detection system, breaks through the limitations of traditional electrochemical biosensor technology, and achieves the purpose of rapid detection of targets, dual signal amplification, improved detection sensitivity and system stability. It has broad application prospects in the field of biological sample detection.
[0014] It should be noted that tetrahedral DNA (TDN), also known as tetrahedral framework nucleic acids (tFANs) and tetrahedral DNA nanostructure, is a tetrahedral structure formed by denaturation and renaturation of four single-stranded DNAs and subsequent complementary base pairing between the chains. It is easy to synthesize and has high biocompatibility.
[0015] As a specific embodiment of the present invention, the method for synthesizing the DNA tetrahedron comprises the following steps:
[0016] The four single-stranded DNAs were mixed evenly with TM buffer to make the total concentration of the single-stranded DNA 2 μM. After oscillation and mixing, the mixture was kept at 95° C. for 2 min and then quickly cooled in ice water to obtain DNA tetrahedron (TDN).
[0017] Furthermore, in combination with the above, the method for preparing the nucleic acid complex comprises the following steps:
[0018] The biotin-modified nucleic acid aptamer (Bio-Apt) was diluted to 4 μM with TE buffer, then annealed at 95°C for 10 min, slowly cooled to room temperature, and then an equal volume of TDN solution was added and incubated at 37°C for 1 h to obtain a nucleic acid complex (Bio-Apt-TDN).
[0019] The rigid structure of TDN self-assembly can enable the nucleic acid aptamer to be more efficiently and stably fixed on the electrode surface, thereby improving the sensitivity of detection and the stability of detection results.
[0020] Furthermore, the DNA tetrahedron includes four DNA chains A, B, C and D, and the nucleotide sequences thereof are shown in SEQ ID NO.1 to SEQ ID NO.4 respectively, and the nucleotide sequence of the biotin-modified nucleic acid aptamer is shown in SEQ ID NO.5.
[0021] Specifically, the sequence of the A chain is 5'-TAG CCT CAA CCC CCA TTT TTT TTT ACA TTC CTAAGT CTG AAA CAT TAC AGC TTG CTA CAC GAG AAG AGC CGC CAT AGT A-3'.
[0022] The sequence of chain B is: 5′-TAT CAC CAG GCA GTT GAC AGT GTA GCA AGC TGT AAT AGATGC GAG GGT CCA ATA C-3′.
[0023] The sequence of chain C is: 5'-TTC AGA CTT AGG AAT GTG CTT CCC ACG TAG TGT CGT TTGTAT TGG ACC CTC GCA T-3'.
[0024] The sequence of chain D is: 5′-TCA ACT GCC TGG TGA TAA AAC GAC ACT ACG TGG GAA TCTACT ATG GCG GCT CTT C-3′.
[0025] The sequence of Bio-Apt is: 5'-TGG GGG TTG AGG CTA AGC CGA-3'.
[0026] It should be noted that the 3' ends of the four DNA chains A, B, C and D are all modified with thiol groups.
[0027] It should be noted that the present invention can select different nucleic acid aptamers according to different antibiotics to be detected, and detect different antibiotics by changing the sequence of the aptamer, which has a good prospect in practical application.
[0028] Furthermore, hydroquinone was selected as an internal reference substance.
[0029] Furthermore, the preparation method of the Fe-CCOF material comprises the following steps:
[0030] The amino-containing monomer, the aldehyde-containing monomer, the Fe- and aldehyde-containing monomer, acetic acid and an organic solvent are uniformly mixed and subjected to a condensation reaction to obtain a Fe-COF material;
[0031] Under an inert atmosphere, the Fe-COF material is carbonized to obtain a Fe-CCOF material.
[0032] The present invention carbonizes the iron-based COF material, and the carbonized Fe-COF (Fe-CCOF) has a graphene-like porous carbon structure, which not only retains the rich pore structure, ultra-high specific surface area and uniformly distributed pore structure of the COF material, but also significantly improves the electrical conductivity of the material. The new CCOF (Fe-CCOF) material doped with atomic-level or nano-level Fe active sites obtained after high-temperature carbonization has excellent catalytic activity, and does not need to compound multiple materials to achieve an electroactive material with ultra-high electrical conductivity, active specific surface area and catalytic activity, thereby improving the guarantee for the construction of highly active electrodes.
[0033] Further, in combination with the preparation method of the above-mentioned Fe-CCOF material, the amino-containing monomer is 1,3,5-tri(4-aminophenyl)benzene, the aldehyde-containing monomer is trimesic acid, and the monomer containing Fe and aldehyde groups is ferrocene carboxaldehyde.
[0034] Furthermore, in combination with the above-mentioned method for preparing the Fe-CCOF material, the molar ratio of the 1,3,5-tris(4-aminophenyl)benzene, trimesic acid and ferrocene carboxaldehyde is (0.16-0.2):(0.16-0.2):(0.16-0.2).
[0035] Further, in combination with the preparation method of the above-mentioned Fe-CCOF material, the organic solvent is acetonitrile, and the ratio of the organic solvent to the total mass of the above-mentioned three monomers is 0.1 mL:1 mg to 0.3 mL:1 mg.
[0036] Further, in combination with the above-mentioned preparation method of Fe-CCOF material, the concentration of acetic acid is 11 mol / L to 12 mol / L, and the ratio of acetic acid to amino-containing monomer is (3 to 4) mL: (0.16 to 0.2) mol.
[0037] Further, in combination with the above-mentioned preparation method of Fe-CCOF material, the temperature of the condensation reaction is 20° C. to 40° C., and the time of the condensation reaction is 12 h to 24 h.
[0038] Further, in combination with the above-mentioned preparation method of Fe-CCOF material, the carbonization temperature is 800° C. to 900° C., and the carbonization time is 3 h to 5 h.
[0039] The optimal carbonization temperature can retain the rich pore structure of the COF material, resulting in an electrode material with high specific surface area, uniform pore distribution and excellent conductivity.
[0040] Furthermore, the COF material is prepared by condensation reaction using 2,5-dimethoxyterephthalaldehyde and 1,3,5-tris(4-aminophenyl)benzene as raw materials.
[0041] Furthermore, the method for preparing the signal-marking COF material comprises the following steps:
[0042] 2,5-dimethoxyterephthalaldehyde and 1,3,5-tri(4-aminophenyl)benzene are added to the mixed organic solution, dispersed evenly, and acetic acid is added to carry out a condensation reaction to obtain a COF material;
[0043] The COF material and the carboxyl-containing organic acid salt are added to water and mixed evenly to obtain a carboxylated COF dispersion; an organic amine is added to the carboxylated COF dispersion and mixed evenly, streptavidin is added, reacted, solid-liquid separated, washed, and the obtained solid is added to a methylene blue solution for adsorption to obtain a signal-labeled COF material.
[0044] The present invention adopts 2,5-dimethoxyterephthalaldehyde and 1,3,5-tri(4-aminophenyl)benzene as monomers to prepare COF materials as carriers for loading signal molecules (methylene blue), utilizes the large π-π conjugated system and ultra-high specific surface area of COF to adsorb a large number of signal molecules, and obtains signal enrichment and sensitization electrochemical labels to improve the accuracy and sensitivity of detection.
[0045] Furthermore, in combination with the above-mentioned method for preparing the signal-labeled COF material, the mass ratio of the 2,5-dimethoxyterephthalaldehyde to 1,3,5-tris(4-aminophenyl)benzene is (8-9):(10-11).
[0046] Furthermore, in combination with the above-mentioned method for preparing the signal-labeled COF material, the mixed organic solution is a mixed solution of 1,4-dioxane, butanol and methanol in a volume ratio of 3 to 5:3 to 5:1, and its volume mass ratio to 2,5-dimethoxyterephthalaldehyde is (4 to 5) mL: (8 to 9) mg.
[0047] Further, in combination with the above-mentioned method for preparing the signal-labeled COF material, the concentration of the acetic acid is 11 mol / L to 12 mol / L, and the mass ratio of the acetic acid to 2,5-dimethoxyterephthalaldehyde is 360 to 405:8 to 9.
[0048] It should be noted that acetic acid is added to the reaction system in two portions: first, 1 / 10 to 1 / 7 of the acetic acid is added, and the reaction is carried out at room temperature for 1 to 2 hours, and then the remaining acetic acid is added and the reaction is continued for 24 to 36 hours.
[0049] Further, in combination with the above-mentioned method for preparing the signal-labeled COF material, the carboxyl-containing organic acid salt is sodium citrate.
[0050] Furthermore, in combination with the preparation method of the signal-labeled COF material, the ratio of the COF material, the carboxyl-containing organic acid salt and water is (0.01-0.02) g: (0.2-0.3) g: (8-12) mL.
[0051] Further, in combination with the above-mentioned method for preparing the signal-labeled COF material, the organic amine is a mixture of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide and N-hydroxysuccinimide.
[0052] It should be noted that after the above reaction, the prepared signal-labeled COF material was added to the BSA solution and incubated at 37° C. for 1 h to block the remaining active sites, and finally the product was separated and resuspended in PBS buffer.
[0053] In a second aspect, the present invention also provides the use of the functionalized nucleic acid probe in the preparation of an electrochemical biosensor for detecting kanamycin.
[0054] In a third aspect, the present invention further provides an electrochemical biosensor for detecting kanamycin, comprising a glassy carbon electrode, and any of the above-described functionalized nucleic acid probes loaded on the glassy carbon electrode.
[0055] In a fourth aspect, the present invention also provides a method for preparing an electrochemical biosensor for detecting kanamycin, comprising the following steps:
[0056] S1, preparation of nucleic acid functionalized Fe-CCOF material:
[0057] S101, using an amino-containing monomer, an aldehyde-containing monomer, and a monomer containing Fe and an aldehyde group as raw materials, subjecting the monomer to condensation reaction and carbonization to obtain a Fe-CCOF material;
[0058] The DNA tetrahedron and the biotin-modified nucleic acid aptamer are mixed and incubated to obtain a nucleic acid complex;
[0059] S102, adding the Fe-CCOF material into water, dispersing it evenly, applying the obtained dispersion droplets onto the surface of the glassy carbon electrode, and drying it to obtain Fe-CCOF / GCE;
[0060] S103, adding the Fe-CCOF / GCE into a chloroauric acid solution, and performing electrodeposition to obtain Au / Fe-CCOF / GCE;
[0061] S104, drop-coating the nucleic acid complex onto the surface of the Au / Fe-CCOF / GCE, and incubating to obtain nucleic acid-functionalized Fe-CCOF material / GCE;
[0062] S2, preparation of signal-labeled COF materials:
[0063] S201, using 2,5-dimethoxyterephthalaldehyde and 1,3,5-tris(4-aminophenyl)benzene as raw materials, performing a condensation reaction to obtain a COF material;
[0064] S202, adding the COF material and the carboxyl-containing organic acid salt into water, mixing them evenly, and obtaining a carboxylated COF dispersion; adding an organic amine into the carboxylated COF dispersion, mixing them evenly, adding streptavidin, reacting, solid-liquid separation, washing, and adding the obtained solid into a methylene blue solution for adsorption, and obtaining a signal-labeled COF material;
[0065] S3, preparation of biosensor:
[0066] The signal-labeled COF material is added to a buffer solution and dispersed evenly, and the dispersed liquid is dropwise coated on the surface of the nucleic acid-functionalized Fe-CCOF material / GCE, incubated, and dried to obtain a biosensor for detecting kanamycin.
[0067] The process of constructing the electrochemical biosensor of the present invention is as follows: Figure 1 As shown. The present invention first prepares Fe-CCOF material and designs a Bio-labeled nucleic acid probe (Bio-Apt-TDN), which is formed by hybridization of a complementary sequence of a Bio-modified nucleic acid aptamer and a nucleic acid aptamer extending from the top of TDN, thereby realizing specific recognition of the target detection object, and the rigid structure of TDN self-assembly can make the nucleic acid aptamer more efficiently and stably fixed on the electrode surface, thereby combining more target detection objects and realizing high-sensitivity detection. Then, the Fe-CCOF material is modified on the GCE surface by a drop coating method, and Au nanoparticles are modified by electrochemical deposition to provide Au-S bond sites for Bio-Apt-TDN to be fixed on the electrode surface, and then the signal-labeled COF material (MB@SA-COF) is fixed on the electrode surface by the specific action of streptavidin-biotin, thereby obtaining an electrochemical biosensor with strong specificity, high sensitivity and stable signal.
[0068] It should be noted that the detailed steps and conditions in S101 are exactly the same as those in the previous preparation method of Fe-CCOF material, and will not be repeated here. The detailed steps and conditions in S2 are exactly the same as those in the previous preparation method of signal marker COF material, and will not be repeated here.
[0069] Further, in combination with the above-mentioned method for preparing a biosensor for detecting kanamycin, in S103, the mass concentration of the chloroauric acid solution is 0.08% to 0.12%, and the electrodeposition is performed by a constant voltage deposition method, the deposition voltage is -0.2V, and the deposition time is 60s.
[0070] In a fifth aspect, the present invention also provides a method for detecting kanamycin, comprising the following steps:
[0071] Step a, adding the above-mentioned biosensor for detecting kanamycin or the biosensor for detecting kanamycin prepared by the above-mentioned method to a kanamycin standard solution of different concentrations for incubation, adding the incubated biosensor to a PBS buffer containing hydroquinone for square wave voltammetry test, and obtaining the oxidation peak current I of hydroquinone from the square wave voltammetry curve HQ and the oxidation peak current I of methylene blue MB , with I HQ / I MB The standard curve was drawn with as the ordinate and the concentration of kanamycin as the abscissa to obtain the linear equation;
[0072] Step b, adding the biosensor to the solution to be tested, incubating, and performing a square wave voltammetry test on the incubated biosensor in a PBS buffer containing hydroquinone to obtain I HQ / IMB , the concentration of kanamycin in the test solution was obtained according to the linear equation.
[0073] The detection mechanism of the present invention is as follows: when kanamycin is contained in the detection system, since the affinity between kanamycin and the nucleic acid aptamer is stronger than the affinity between the aptamer and TDN, the kanamycin / Bio-Apt / signal marker COF complex will be separated from the composite probe (e.g. Figure 1 As shown), it enters the detection system. The higher the kanamycin content, the more kanamycin / Bio-Apt / signal marker COF complexes are detached, that is, more methylene blue is detached, resulting in a lower oxidation peak current of methylene blue; at the same time, the more kanamycin / Bio-Apt / signal marker COF complexes are detached, the stronger the conductivity of the electrode, so that the oxidation peak current of hydroquinone is higher. The relationship between the ratio of the oxidation peak currents of hydroquinone and methylene blue and the kanamycin concentration can be used to obtain a linear equation, and the concentration of kanamycin in the test solution can be calculated according to the linear equation.
[0074] The kanamycin detection method provided by the present invention uses hydroquinone as an internal reference substance and a complex formed by nucleic acid-functionalized Fe-CCOF and signal-labeled COF as a probe, thereby achieving specific detection of kanamycin and avoiding interference from instruments or the environment, improving the signal-to-noise ratio, enhancing the sensitivity, accuracy and detection range of detection, and does not require expensive large-scale equipment or instruments. The method has good application and development prospects in on-site rapid detection. BRIEF DESCRIPTION OF THE DRAWINGS
[0075] Figure 1 A schematic diagram of the process of constructing an electrochemical biosensor according to the present invention;
[0076] Figure 2 Infrared spectra (FT-IR) of Fe-COF and Fe-CCOF prepared in Example 1;
[0077] Figure 3 XRD patterns of Fe-COF and Fe-CCOF prepared in Example 1, wherein a, Fe-COF, b, Fe-CCOF;
[0078] Figure 4 The SEM, TEM and EDS spectra of Fe-COF and Fe-CCOF prepared in Example 1, wherein (A) SEM image of Fe-COF, (B) SEM image of Fe-CCOF, (C) TEM image of Fe-COF, (D) TEM image of Fe-CCOF, (E) HR-TEM image of Fe-CCOF, (F) EDS spectra of Fe-CCOF;
[0079] Figure 5XPS graphs of Fe-COF and Fe-CCOF prepared in Example 1, wherein: (A) full spectrum of Fe-COF, (B) full spectrum of Fe-CCOF, (C) C1s spectrum of Fe-CCOF, (D) N1s spectrum of Fe-CCOF, (E) O1s spectrum of Fe-CCOF, and (F) Fe 2p of Fe-CCOF;
[0080] Figure 6 The nitrogen adsorption-desorption curves and pore size distribution diagrams of Fe-COF and Fe-CCOF prepared in Example 1, wherein (A) the nitrogen adsorption-desorption curve diagram of Fe-COF, (B) the nitrogen adsorption-desorption curve diagram of Fe-CCOF, (C) the pore size distribution diagram of Fe-COF, and (D) the pore size distribution diagram of Fe-CCOF;
[0081] Figure 7 COF prepared in Example 1 TAPB-DMTP FT-IR spectrum of
[0082] Figure 8 COF prepared in Example 1 TAPB-DMTP SEM images of
[0083] Fig. 9 COF prepared in Example 1 TAPB-DMTP XRD pattern of
[0084] Fig.10 COF prepared in Example 1 TAPB-DMTP UV-visible absorption diagram of
[0085] Fig.11 Cyclic voltammetry curves of different electrode materials prepared in Example 1, including (a) bare GCE, (b) Fe-CCOF / GCE, (c) AuNPs / Fe-CCOF / GCE, (d) Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, (e) BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, (f) MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, and (g) Kana / MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE;
[0086] Fig.12EIS graphs of different electrode materials prepared in Example 1, including (a) bare GCE, (b) Fe-CCOF / GCE, (c) AuNPs / Fe-CCOF / GCE, (d) Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, (e) BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, (f) MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE, and (g) Kana / MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE;
[0087] Fig.13 SWV diagrams of different electrode materials prepared in Example 1, including (a) COF / GCE, (b) Fe-COF / GCE, (c) Fe-CCOF / GCE, (d) Au / Fe-CCOF / GCE, (e) Bio-Apt-TDN / Au / Fe-CCOF / GCE, and (f) BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE;
[0088] Fig.14 SWV graphs of MB@SA-COF / BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE electrodes after incubation in PBS buffer with different concentrations of kanamycin, including (a) MB@SA-COF / BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE, (b) Kana / MB@SA-COF / BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE ((1 nM) and (c) (1 μM);
[0089] Fig.15 SWV response diagram and linear relationship diagram of the electrochemical biosensor constructed in Example 1 to different concentrations of kanamycin;
[0090] Fig.16 A comparison of the current responses of the electrochemical biosensor constructed in Example 1 to different antibiotics, including a blank control (a), chloramphenicol (b), tetracycline (c), oxytetracycline (d), norfloxacin (e), ampicillin (f), gentamicin (g), kanamycin (h) and a mixture of all interferents (I);
[0091] Fig.17 The reproducibility test results of the electrochemical biosensor constructed in Example 1;
[0092] Fig.18 The stability test results of the electrochemical biosensor constructed in Example 1. DETAILED DESCRIPTION
[0093] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0094] In order to better illustrate the embodiments of the present invention, further examples are given below.
[0095] The preparation method of Bio-Apt-TDN used in the following examples is as follows:
[0096] The four DNA chains A, B, C and D were mixed evenly with TM buffer to make the total concentration of single-stranded DNA 2μM, and after shaking and mixing, they were kept at 95℃ for 2min, and then quickly cooled in ice water to obtain DNA tetrahedron (TDN). The biotin-modified nucleic acid aptamer (Bio-Apt) was diluted to 4μM with TE buffer, then annealed at 95℃ for 10min, slowly cooled to room temperature, and then an equal volume of TDN solution was added, and incubated at 37℃ for 1h to obtain a nucleic acid complex, namely Bio-Apt-TDN solution.
[0097] The sequence of the A chain is 5′-TAG CCT CAA CCC CCA TTT TTT TTT ACA TTC CTA AGT CTGAAA CAT TAC AGC TTG CTA CAC GAG AAG AGC CGC CAT AGT A-3′.
[0098] The sequence of chain B is: 5′-TAT CAC CAG GCA GTT GAC AGT GTA GCA AGC TGT AAT AGATGC GAG GGT CCA ATA C-3′.
[0099] The sequence of chain C is: 5'-TTC AGA CTT AGG AAT GTG CTT CCC ACG TAG TGT CGT TTGTAT TGG ACC CTC GCA T-3'.
[0100] The sequence of chain D is: 5′-TCA ACT GCC TGG TGA TAA AAC GAC ACT ACG TGG GAA TCTACT ATG GCG GCT CTT C-3′.
[0101] The sequence of Bio-Apt is: 5'-TGG GGG TTG AGG CTA AGC CGA-3'.
[0102] The 3' ends of the four DNA chains A, B, C and D are all modified with thiol groups.
[0103] The GCE electrodes used in the following examples were first modified with 1.0 μm, 0.3 μm and 0.05 μm α-Al 2 O 3 The bare GCE was polished on suede with polishing powder until the electrode surface was bright, and then the electrode was ultrasonically cleaned with deionized water and ethanol in sequence. Finally, the electrode surface was blown dry with nitrogen to obtain a clean GCE electrode.
[0104] Example 1
[0105] The present invention provides a method for preparing an electrochemical biosensor for detecting kanamycin, comprising the following steps:
[0106] 1. Preparation of Fe-CCOF materials
[0107] 56.2 mg of 1,3,5-tris(4-aminophenyl)benzene (TAPB), 25.9 mg of triphenylaldehyde (Tf), 12.85 mg of ferrocenecarboxaldehyde (FcCHO), 3.2 mL of 12M acetic acid and 20 mL of acetonitrile were mixed evenly under ultrasonic conditions, then stirred at 900 rpm for 15 h at room temperature, centrifuged, and the precipitate was washed with acetonitrile, triethylamine / ethanol (1:9, v / v) and ethanol in turn, and dried at 70°C for 15 h to obtain Fe-COF material; the above Fe-COF material was placed in a tubular furnace and carbonized at 850°C for 4 h under argon atmosphere to obtain Fe-CCOF material.
[0108] 2. Preparation of MB@SA-COF
[0109] 8.7 mg 2,5-dimethoxyterephthalaldehyde (TAPB) and 10.5 mg 1,3,5-tris(4-aminophenyl)benzene (DMTP) were added to 4.5 mL of a mixed solution of 1,4-dioxane-butanol-methanol (4:4:1, v / v / v), and ultrasonically dispersed for 25 min. Then, 55 μL 12 M acetic acid was added to the system under stirring conditions, and the system was stirred for 1 h at room temperature. After standing, 480 μL 12 M acetic acid was added to the reaction system, and the system was kept standing for 30 h to allow it to react fully. After centrifugation, the precipitate was washed with tetrahydrofuran and acetone, and dried at 70 ° C for 7 h to obtain COF TAPB-DMTP .
[0110] Weigh 0.01g of the above COF TAPB-DMTPand 0.2g sodium citrate, added to 10mL deionized water, stirred for 1h to obtain a carboxylated COF solution. 0.5mg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and 0.6mg N-hydroxysuccinimide (NHS) solution were dissolved in 1mL water, then added to the above carboxylated COF solution, incubated at room temperature for 2h, then washed with PBS buffer, and the washed carboxylated COF was dispersed in 10mL PBS buffer, 50μL 1mg / mL streptavidin (SA) was added, incubated overnight, washed, and SA-COF was obtained; SA-COF was dispersed in 500μL 25mg / mL methylene blue (MB) solution, and oscillated in an oscillator for 12h to obtain MB@SA-COF. Finally, MB@SA-COF was added to 1% BSA solution and incubated at 37°C for 1 h to block the remaining binding sites. Finally, the product was separated and resuspended in 2 mL PBS buffer to obtain MB@SA-COF dispersion.
[0111] 3. Construction of modified electrodes
[0112] 1 mg of the Fe-CCOF material prepared above was weighed and added into 1 mL of ultrapure water and dispersed evenly to obtain a Fe-CCOF dispersion. 6 μL of the Fe-CCOF dispersion was evenly drop-coated onto the surface of the GCE electrode and dried at room temperature to obtain Fe-CCOF / GCE.
[0113] Fe-CCOF / GCE was immersed in 0.1% HAuCl 4 In the solution, constant potential deposition was carried out, the constant potential was set to -0.2 V, and the deposition time was 60 s to obtain AuNPs / Fe-CCOF / GCE.
[0114] 6 μL of Bio-Apt-TDN solution (2 μM) was dropped on the surface of AuNPs / Fe-CCOF / GCE and incubated at 37°C for 2 h to obtain Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE. 6 μL of 1% BSA solution was dropped on the surface of Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37°C for 30 min to block the remaining binding sites and prevent nonspecific adsorption of Bio-Apt-TDN, and then washed with PBS buffer to remove loosely adsorbed aptamers to obtain BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0115] 6 μL of MB@SA-COF dispersion was dropwise coated on the surface of BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37 °C for 2 h to obtain MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0116] The above-mentioned MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE electrode was added to PBS buffer containing 1 nM kanamycin (Kana) and incubated at 37°C for 80 min. The Bio-Apt in the probe Bio-Apt-TDN specifically bound to Kana, causing it to detach from the electrode surface, thereby obtaining Kana / MB@SA-COF / BSA / TDN / AuNPs / Fe-CCOF / GCE.
[0117] Example 2
[0118] The present invention provides a method for preparing an electrochemical biosensor for detecting kanamycin, comprising the following steps:
[0119] 1. Preparation of Fe-CCOF materials
[0120] 67.44 mg of 1,3,5-tri(4-aminophenyl)benzene, 31.08 mg of isophthalic acid, 25.7 mg of ferrocenecarboxaldehyde, 4 mL of 12M acetic acid and 25 mL of acetonitrile were mixed evenly under ultrasonic conditions, then stirred at 800 rpm at room temperature for 24 h, centrifuged, and the precipitate was washed with acetonitrile, triethylamine / ethanol (1:9, v / v) and ethanol in turn, and dried at 80°C for 12 h to obtain Fe-COF material; the above Fe-COF material was placed in a tubular furnace and carbonized at 800°C for 5 h under argon atmosphere to obtain Fe-CCOF material.
[0121] 2. Preparation of MB@SA-COF
[0122] 8 mg of 2,5-dimethoxyterephthalaldehyde and 10 mg of 1,3,5-tris(4-aminophenyl)benzene were added to 4 mL of a mixed solution of 1,4-dioxane-butanol-methanol (3:3:1, v / v / v), and ultrasonically dispersed for 20 min. Then, 50 μL of 12 M acetic acid was added to the system under stirring conditions, and the system was stirred for 1 h at room temperature. After standing, 450 μL of 12 M acetic acid was added to the reaction system, and the system was kept standing for 24 h to allow it to react fully. After centrifugation, the precipitate was washed with tetrahydrofuran and acetone, and dried at 60 ° C for 8 h to obtain COF TAPB-DMTP .
[0123] Weigh 0.015g of the above COF TAPB-DMTPand 0.25g sodium citrate, added to 10mL deionized water, stirred for 1h to obtain a carboxylated COF solution. 0.75mg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and 0.9mg N-hydroxysuccinimide (NHS) were dissolved in 1mL water, then added to the above carboxylated COF solution, incubated at room temperature for 1h, then washed with PBS buffer, and the washed carboxylated COF was dispersed in 10mL PBS buffer, 50μL 1mg / mL streptavidin was added, incubated overnight, washed, and SA-COF was obtained; SA-COF was dispersed in 500μL 25mg / mL methylene blue solution, and oscillated in an oscillator for 12h to obtain MB@SA-COF. Finally, MB@SA-COF was added to 1% BSA solution and incubated at 37°C for 1 h to block the remaining binding sites. Finally, the product was separated and resuspended in 2 mL PBS buffer to obtain MB@SA-COF dispersion.
[0124] 3. Construction of modified electrodes
[0125] 1.5 mg of the Fe-CCOF material prepared above was weighed and added into 1 mL of ultrapure water and dispersed evenly to obtain a Fe-CCOF dispersion. 6 μL of the Fe-CCOF dispersion was evenly drop-coated onto the surface of the GCE electrode and dried at room temperature to obtain Fe-CCOF / GCE.
[0126] Fe-CCOF / GCE was immersed in 0.1% HAuCl 4 In the solution, constant potential deposition was carried out, the constant potential was set to -0.2 V, and the deposition time was 60 s to obtain AuNPs / Fe-CCOF / GCE.
[0127] 6 μL of Bio-Apt-TDN solution (2 μM) was dropped on the surface of AuNPs / Fe-CCOF / GCE and incubated at 37°C for 2 h to obtain Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE. 6 μL of 1% BSA solution was dropped on the surface of Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37°C for 30 min to block the remaining binding sites and prevent nonspecific adsorption of Bio-Apt-TDN, and then washed with PBS buffer to remove loosely adsorbed aptamers to obtain BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0128] 6 μL of MB@SA-COF dispersion was dropwise coated on the surface of BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37 °C for 2 h to obtain MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0129] Example 3
[0130] The present invention provides a method for preparing an electrochemical biosensor for detecting kanamycin, comprising the following steps:
[0131] 1. Preparation of Fe-CCOF materials
[0132] 63.5 mg of 1,3,5-tris(4-aminophenyl)benzene, 28.2 mg of isophthalic acid, 18.5 mg of ferrocenecarboxaldehyde, 3.6 mL of 12M acetic acid and 22 mL of acetonitrile were mixed evenly under ultrasonic conditions, then stirred at 1000 rpm for 12 h at room temperature, centrifuged, and the precipitate was washed with acetonitrile, triethylamine / ethanol (1:9, v / v) and ethanol in sequence, and dried at 60°C for 24 h to obtain Fe-COF material; the above Fe-COF material was placed in a tubular furnace and carbonized at 900°C for 3 h under argon atmosphere to obtain Fe-CCOF material.
[0133] 2. Preparation of MB@SA-COF
[0134] 9 mg of 2,5-dimethoxyterephthalaldehyde and 11 mg of 1,3,5-tris(4-aminophenyl)benzene were added to 5 mL of a mixed solution of 1,4-dioxane-butanol-methanol (5:5:1, v / v / v), and ultrasonically dispersed for 30 min. Then, 60 μL of 12 M acetic acid was added to the system under stirring conditions, and the system was stirred for 2 h at room temperature. After standing, 500 μL of 12 M acetic acid was added to the reaction system, and the system was kept standing for 36 h to allow it to react fully. After centrifugation, the precipitate was washed with tetrahydrofuran and acetone, and dried at 80 ° C for 6 h to obtain COF TAPB-DMTP .
[0135] Weigh 0.02g of the above COF TAPB-DMTPand 0.3g sodium citrate, added to 10mL deionized water, stirred for 1h to obtain a carboxylated COF solution. 1.0mg 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) and 1.2mg N-hydroxysuccinimide (NHS) were dissolved in 1mL water, then added to the above carboxylated COF solution, incubated at room temperature for 1.5h, then washed with PBS buffer, and the washed carboxylated COF was dispersed in 10mL PBS buffer, 80μL 1mg / mL streptavidin was added, incubated overnight, washed, and SA-COF was obtained; SA-COF was dispersed in 500μL 25mg / mL methylene blue solution, and oscillated in an oscillator for 12h to obtain MB@SA-COF. Finally, MB@SA-COF was added to 1% BSA solution and incubated at 37°C for 1 h to block the remaining binding sites. Finally, the product was separated and resuspended in 2 mL PBS buffer to obtain MB@SA-COF dispersion.
[0136] 3. Construction of modified electrodes
[0137] 2 mg of the Fe-CCOF material prepared above was weighed and added into 2 mL of ultrapure water and dispersed evenly to obtain a Fe-CCOF dispersion. 6 μL of the Fe-CCOF dispersion was evenly drop-coated on the surface of the GCE electrode and dried at room temperature to obtain Fe-CCOF / GCE.
[0138] Fe-CCOF / GCE was immersed in 0.1% HAuCl 4 In the solution, constant potential deposition was carried out, the constant potential was set to -0.2 V, and the deposition time was 60 s to obtain AuNPs / Fe-CCOF / GCE.
[0139] 6 μL of Bio-Apt-TDN solution (2 μM) was dropped on the surface of AuNPs / Fe-CCOF / GCE and incubated at 37°C for 2 h to obtain Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE. 6 μL of 1% BSA solution was dropped on the surface of Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37°C for 30 min to block the remaining binding sites and prevent nonspecific adsorption of Bio-Apt-TDN, and then washed with PBS buffer to remove loosely adsorbed aptamers to obtain BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0140] 6 μL of MB@SA-COF dispersion was dropwise coated on the surface of BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE and incubated at 37 °C for 2 h to obtain MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE.
[0141] Example 4
[0142] This embodiment provides a method for detecting kanamycin, which specifically comprises the following steps:
[0143] Step a, adding the above-mentioned biosensor for detecting kanamycin or the biosensor for detecting kanamycin prepared by the above-mentioned method to a kanamycin standard solution of different concentrations for incubation, adding the incubated biosensor to a PBS buffer containing hydroquinone for square wave voltammetry test, and obtaining the oxidation peak current I of hydroquinone from the square wave voltammetry curve HQ and the oxidation peak current I of methylene blue MB , with I HQ / I MB The standard curve was drawn with as the ordinate and the concentration of kanamycin as the abscissa to obtain the linear equation;
[0144] Step b, adding the biosensor to the solution to be tested, incubating, and performing a square wave voltammetry test on the incubated biosensor in a PBS buffer containing hydroquinone to obtain I HQ / I MB , the concentration of kanamycin in the test solution was obtained according to the linear equation.
[0145] Material characterization
[0146] 1. Characterization of Fe-COF and Fe-CCOF
[0147] The structures of Fe-COF and Fe-CCOF prepared in Example 1 were characterized by FT-IR. Figure 2 As shown in the figure, TAPB has a -1 、3345cm -1 and 3211cm -1 There is an absorption peak at 1698cm -1 There is a sharp absorption peak at the position, which is mainly caused by the stretching of C=O bond. Fe-COF is at 1623cm -1 The absorption peak of C=N bond appears at 3423cm -1 and 1698cm -1 The absorption peak at 1397 cm / s weakened or even disappeared, indicating that an amine-aldehyde condensation reaction occurred between TAPB and Tf.-1 and 1136cm -1 ), monosubstituted metallocene CH bond (1010cm -1 ), ring tilt (526cm -1 ) and Fe-C stretching (485cm -1 ) strongly indicates successful modification of Fc, while no C=O stretching (1677 cm -1 ), indicating that Fc is covalently bound to the framework, proving the successful synthesis of Fe-COF. However, the characteristic peaks of Fe-CCOF disappear after carbonization due to the degradation of some functional groups.
[0148] The XRD patterns of Fe-COF and Fe-CCOF prepared in Example 1 are as follows: Figure 3 As shown in the figure, the main structural characteristic peaks before and after carbonization are the same, and the peak at θ = 50.9° confirms that the γ-Fe phase has always existed. The peak at about 29.9° corresponds to Fe 3 O 4 (2 2 0) crystal plane, and its diffraction peak is more obvious after carbonization, which indicates that the material may be more easily oxidized after carbonization. However, no characteristic peak of carbon is seen in the figure, which may be because the presence of iron compounds submerges the weak carbon peak. In addition, after calcination, some new characteristic diffraction peaks appear at 41.6°, 43.5°, and 63.5°, corresponding to the signals of Fe 3 The (0 3 1) crystal plane of C and the (1 1 0) and (2 0 0) lattice planes of Fe atoms. Based on the above results, the successful synthesis of Fe-CCOF materials after carbonization was demonstrated.
[0149] The SEM, TEM and EDS images of Fe-COF and Fe-CCOF prepared in Example 1 are as follows: Figure 4 shown. Figure 4 (A) shows that the particle size of the synthesized Fe-COF is relatively uniform, about 400nm. Figure 4 The Fe-CCOF carbon material formed by carbonization of Fe-COF in (B) retains the original spherical morphology of Fe-COF, but the size is reduced by about 50nm. Figure 4 (A) and Figure 4 (B) It can be found that the surface of the Fe-CCOF carbon material obtained by carbonization of Fe-COF becomes rougher than that before carbonization, which is mainly due to the decomposition and collapse of the material during the pyrolysis process. In addition, in order to verify whether the graphite C is successfully loaded on the surface of the Fe-CCOF carbon material after carbonization, the Fe-CCOF carbon material is subjected to TEM analysis, such as Figure 4 (D) and Figure 4 As shown in (E), it can be observed that the pores of Fe-CCOF carbon material are more prominent after carbonization. Figure 4In (E), obvious C lattice fringes can be seen. In order to better observe the distribution of elements contained in the material on Fe-CCOF, EDS element mapping characterization of Fe-CCOF carbon material was performed. Figure 4 As shown in (F), it can be observed that C, N, O, and Fe are uniformly loaded on the Fe-CCOF carbon material.
[0150] The elemental compositions of Fe-COF and Fe-CCOF prepared in Example 1 were tested by X-ray photoelectron spectroscopy (XPS). Figure 5 (A) and Figure 5 (B) It is not difficult to find that the C content in Fe-CCOF is higher than that in Fe-COF, and the N content in the material decreases after carbonization, which is mainly due to the decomposition of the nitrogen-containing groups in Fe-COF after carbonization. The XPS PEAK1 software was used to fit and analyze the C1s, N 1s, O 1s and Fe 2p spectra of Fe-CCOF to further determine the surface electronic state and chemical composition of Fe-CCOF. Figure 5 As shown in (C), the C1s spectrum of Fe-CCOF contains three peaks, corresponding to CC / C=C (284.8 eV), C=N (286.1 eV), and C=O (290.2 eV). Figure 5 (D) is the high-resolution spectrum of N1s. The three peaks at 399.7 eV, 401.10 eV and 404.50 eV correspond to C=NC, C-NH 2 And Π=Π*. Figure 5 (E) is the XPS spectrum of O1s in Fe-CCOF, and the peak at the binding energy of 531.6 eV belongs to C=O. Figure 5 (F) is the spectrum of Fe 2p. The peaks at binding energies of 707.2 eV and 720.09 eV belong to Fe 2p, respectively. 3 / 2 , Fe 2p 1 / 2 .
[0151] The nitrogen adsorption-desorption curves and particle size distribution diagrams of Fe-COF and Fe-CCOF prepared in Example 1 are shown in Figure 6 As shown. Figure 6 As shown in (A), the nitrogen adsorption-desorption curve of Fe-COF is a type III isotherm, and the specific surface area calculated by the BET method is 589.04 m 2 ·g -1 , total pore volume 0.433 cm 3 ·g -1 , of which the micropore volume is 0.158 cm 3 ·g -1, indicating that the structure contains fewer mesopores and macropores. The nitrogen adsorption-desorption curve of Fe-CCOF is also a type III isotherm, in which the specific surface area of Fe-CCOF after carbonization is 729.75 m 2 ·g -1 The total pore volume is 0.63854 cm 3 ·g -1 , and the micropore volume is 0.310cm 3 ·g -1 ,from Figure 6 As can be seen in (B), at low relative pressure (P / P 0 <0.1) has a larger increase, and high relative pressure (P / P 0 >0.8), the increase is small, indicating that Fe-CCOF is a microporous material. From the above analysis, it can be seen that structural micropores are the main pore type of Fe-COF materials. We further use the BJH (Barrett-Joyner-Halenda) calculation method to analyze the pore size distribution of Fe-COF and Fe-CCOF. Figure 6 As shown in (C) and (D), the pores of Fe-COF material are concentrated at 1-1.5 nm, and the corresponding micropore volume is 0.158 cm 3 ·g -1 The pore size of Fe-CCOF carbon material is distributed in small amounts at 1-1.5 nm, and concentrated at 0.5 nm. The micropore volume is 0.310 cm 3 ·g -1 (accounting for 48.55%).
[0152] 2. Characterization of MB@SA-COF
[0153] COF prepared in Example 1 TAPB-DMTP The FT-IR spectrum of Figure 7 As shown in the figure, 3422cm -1 、3345cm -1 、3211cm -1 The characteristic peak at 1679 cm is attributed to the NH stretching vibration of TAPB. -1 The characteristic peak at is attributed to the C=O stretching band of DMTP. TAPB-DMTP At 1613cm -1 The absorption peak at 20° becomes stronger, indicating that the aldehyde group of DMTP condenses with the amino group of TAPB to form an imine bond. TAPB-DMTP There are aldehyde groups (1679 cm -1 ) and amino (3361cm -1) peak. This indicates that after the material is synthesized, they are greatly weakened by the reversible reaction, indicating that the condensation reaction is very thorough, confirming the COF TAPB-DMTP Successful synthesis of materials.
[0154] Figure 8 COF TAPB-DMTP From the scanning electron microscope image, it can be seen that COF has a spherical structure with a particle size of about 400nm and uniform shape and size. In addition, its surface is rough, with slight protrusions on the edge and convex domains of 30 to 50nm, indicating that the COF sphere is composed of grains containing regular channels arranged along the radial direction of the sphere.
[0155] Fig. 9 COF TAPB-DMTP The XRD pattern shows that the characteristic diffraction peak at 2.79° belongs to the (1 0 0) crystal plane, indicating that the prepared material has good crystallinity. The other diffraction peaks belong to the (1 1 0), (2 0 0), (2 1 0), (2 2 0) and (0 0 1) crystal planes, and are located at 4.84°, 5.60°, 7.39°, 9.73° and 25.42°, respectively. The results show that the XRD spectrum is consistent with the literature, indicating that COF TAPB-DMTP Successfully synthesized and of good quality.
[0156] In order to verify the successful modification of MB and SA on COF, the COF before and after modification was characterized by UV spectroscopy, such as Fig.10 As shown. The UV curve of COF has one UV absorption peak at 488nm, and the UV curve of MB shows two UV absorption peaks, which are attributed to the pp* transition of the benzene ring at 293nm and the np* transition of C=N at 665nm. The UV curve of SA has one UV absorption peak at 258nm. Due to the strong connection between the loaded MB and SA, the UV curve of MB@SA-COF shows enhanced absorbance at 246.97nm, 292.97nm, and 662nm, respectively, proving the successful preparation of the MB@SA-COF complex.
[0157] 3. Electrochemical Characterization of Modified Electrodes
[0158] To characterize the sensor fabrication process, 5 mM [Fe(CN) 6 ] 3- Cyclic voltammetry (CV) measurements were performed in solution, as Fig.11As shown. The CV current response of Fe-CCOF / GCE (curve b) prepared in Example 1 has a larger current response than that of bare GCE (curve a), which indicates that Fe-CCOF nanomaterials promote the transfer of electrons and have excellent electrical conductivity. When gold nanoparticles are loaded onto the electrode surface by electrodeposition, the redox peak current of AuNPs / Fe-CCOF / GCE electrode (curve c) increases relatively, indicating that AuNPs can accelerate electron transfer. In addition, after incubation (curve e) of Bio-Apt-TDN (curve d) and BSA, due to the negative charge of the DNA molecule on the sensing interface having a phosphate backbone, and the presence of steric hindrance in the DNA molecule, coupled with the poor electrical conductivity of BSA, the current is further reduced, proving the successful immobilization of kanamycin nucleic acid aptamers and the successful blocking of BSA. Subsequently, when MB@SA-COF is combined (curve f), due to the poor electrical conductivity of the SA protein modified on the electrode surface, electron transfer is hindered, resulting in a further decrease in the redox peak current. Finally, when kanamycin was incubated on the electrode surface (curve g), the nucleic acid aptamer chain specifically bound to kanamycin and fell off the electrode surface, reducing the inhibitory effect of DNA aptamer and MB@SA-COF on electron transfer and increasing the peak current. The change in redox peak current indicates the successful preparation of the sensing interface and each step of the modified electrode.
[0159] In the presence of 5.0 mM [Fe(CN) 6 ] 3- / 4- The impedance test was carried out in 0.1M KCl solution (frequency: 0.1×10 5 ~1×10 5 Hz), and the impedance data was fitted using ZSimpWin software to obtain the Nyquist spectrum. Fig.12As shown. Among them, the impedance value of bare GCE is 89Ω (curve a). When Fe-CCOF nanomaterials are modified on the electrode surface, the impedance value becomes 63Ω, which is due to the fact that the conductive Fe-CCOF promotes charge transfer (curve b). After AuNPs are loaded on the surface of Fe-CCOF / GCE, the conductivity of the material is more effectively enhanced, and the impedance value of AuNPs / Fe-CCOF / GCE is reduced to 50Ω (curve c). With the step-by-step modification of Bio-Apt-TDN (curve d), BSA (curve e), and MB@SA-COF (curve f), due to the poor conductivity of each layer and the obstruction of electron transfer, the impedance value gradually increases, showing the following trend: MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE>BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE>Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE. After incubation with kanamycin, the aptamer on the electrode surface specifically binds to kanamycin and detaches from the electrode surface, and the impedance value of the modified electrode decreases (curve g). These experimental results once again prove that each layer of material is successfully fixed on the GCE surface.
[0160] 4. Feasibility verification of electrochemical biosensor
[0161] In order to verify the feasibility of constructing ratiometric electrochemical biosensors, the electrochemical responses of electrodes modified with different materials were studied in PBS buffer (0.05 M, pH 7.0, containing 200 μM hydroquinone) using the SWV method. Fig.13 As shown in the figure, a small oxidation peak appeared in COF / GCE (a), indicating that COF has a certain catalytic activity for hydroquinone (HQ). Compared with the previous COF / GCE (a), the oxidation peak current of Fe-COF / GCE (b) was slightly increased, indicating that Fe-COF has a higher catalytic activity for HQ. When Fe-COF was carbonized to form Fe-CCOF (c), there was a larger oxidation peak current response on the electrode, indicating that Fe-CCOF has better electrocatalytic activity for HQ. Therefore, the electrocatalytic oxidation of HQ by Fe-CCOF can be used as an internal reference signal in the ratiometric electrochemical biosensor system. In addition, with the introduction of AuNPs, the conductivity of the material is enhanced, which further accelerates the electron migration rate. Au / Fe-CCOF / GCE (d) shows the strongest current response to HQ. When Bio-Apt-TDN (e) and BSA (f) are gradually modified, the electron transfer is hindered and the electron transfer rate is reduced, resulting in a decrease in the HQ peak current.
[0162] MB@SA-COF / BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE was incubated in PBS buffer containing different concentrations (1 nm, 1 μM) of kanamycin, and then placed in PBS buffer (0.05 M, pH 7.0, containing 200 μM hydroquinone) for SWV test. The electrochemical responses before and after incubation are shown in Figure 2. Fig.14 As shown in the figure, a new MB oxidation peak appears at -0.22V, and as the Kana concentration continues to increase, the corresponding HQ oxidation current continues to increase, and the MB oxidation peak signal gradually decreases, showing an obvious change. Therefore, it is feasible to use the oxidation signals of HQ and MB to construct a ratio sensing system for the quantitative detection of Kana.
[0163] Quantitative Detection of Kanamycin by Electrochemical Biosensor
[0164] Detection limit and linear range
[0165] In order to evaluate the performance of the ratiometric electrochemical biosensor constructed in the present invention in detecting kanamycin, the PBS buffer containing different concentrations of kanamycin was detected by the SWV method.
[0166] MB@SA-COF / BSA / Bio-Apt-TDN / Au / Fe-CCOF / GCE prepared in Example 1 was incubated in PBS buffer containing different concentrations (1 pM to 1 μM) of kanamycin, and then placed in PBS buffer (0.05 M, pH 7.0, containing 200 μM hydroquinone) for SWV testing at a scan rate of 100 mV / s. The results are shown in FIG. Fig.15 As shown in (A), it can be seen from the figure that as the concentration of kanamycin increases, the oxidation peak current of HQ gradually increases, and the oxidation peak current of MB gradually decreases. HQ / I MB The current ratio is the horizontal axis, and the Log value of kanamycin concentration is the horizontal axis to draw a standard curve, such as Fig.15 (B) shows that the linear regression equation is: HQ / I MB (μA)=0.102logC Kana (nM) + 0.483, the detection limit is 0.4pM (S / N = 3), in the range of kanamycin concentration from 1pM to 1μM, I HQ / I MB The ratio signal showed a good linear relationship with the Kana concentration.
[0167] It is thus proved that the sensor constructed by the present invention has excellent detection sensitivity, which is mainly attributed to the following factors: (1) Fe-CCOF and MB@SA-COF have good biocompatibility. Since Fe-CCOF has a good electrocatalytic oxidation effect on HQ, it can be used as an internal reference signal to improve the sensitivity of the sensor; (2) The intrinsic cavity inside COF can not only promote the fixation of MB on the porous structure, but also promote their penetration into the pores to form MB@COF, which further increases the number of MB binding and promotes signal amplification; (3) Bio-Apt-TDN and AuNPs are connected by Au-S bonds, which enhances the immobilization of Bio-Apt-TDN. In addition, the three-dimensional structure of DTN enables the aptamer chain to be more stably fixed on the electrode surface and can specifically bind to more Kana, thereby improving the detection performance.
[0168] Anti-interference test
[0169] In addition to sensitivity, the selectivity of the sensing platform for kanamycin detection is also one of the important factors to measure the quality of the detection method. Since the actual sample may contain other antibiotics that interfere with the inspection effect, the electrochemical biosensor constructed in Example 1 was used to test its anti-interference ability to other antibiotics.
[0170] The MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE electrode prepared in Example 1 was added to PBS buffer containing different antibiotics, the antibiotic concentration was 1nm, and the electrode was incubated at 37°C for 80min, and then placed in PBS buffer (0.05M, pH7.0, containing 200μM hydroquinone) for SWV test, with a scan rate of 100mV / s. Antibiotics include chloramphenicol (CHL), tetracycline (TC), oxytetracycline (OTC), norfloxacin (NFX), ampicillin (AMP) and gentamicin (GEN). The electrode was placed in a PBS buffer containing all antibiotics for incubation, and the SWV test was performed in the same manner. And the blank control group was incubated in PBS buffer without adding antibiotics, and the SWV test was performed in the same manner after incubation.
[0171] The results are as follows Fig.16 As shown, it can be seen that the signal responses of the blank group (a), chloramphenicol (b), tetracycline (c), oxytetracycline (d), norfloxacin (e), ampicillin (f) and gentamicin (g) are significantly lower than the current signal response of kanamycin (h). And, after continuing to add all interfering substances and mixing with kanamycin (I), an obvious current response is shown again. It can be seen that the constructed sensor can selectively detect kanamycin coexisting with interfering substances, indicating that the electrochemical biosensor constructed by the present invention has higher selectivity.
[0172] Repeatability test
[0173] Using the method of Example 1, six independent Kana / MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE electrodes were prepared under the same conditions, and the PBS buffer containing kanamycin was repeatedly tested. Fig.17 As shown, the results show that the relative standard deviation of six electrodes tested simultaneously on PBS buffer containing 1 nM kanamycin is 1.6%, indicating that the ratio electrochemical biosensor constructed in the present invention has good reproducibility.
[0174] Stability test
[0175] The electrochemical biosensor prepared in Example 1 was tested in PBS buffer containing 1 nM kanamycin every 2 days to evaluate the stability of the electrochemical biosensor. Fig.18 As shown, the results prove that even after 10 days, the current value still maintains 94.15% of its initial current response. The above results show that the prepared ratiometric electrochemical biosensor has good reproducibility and long-term stability.
[0176] Application in actual products
[0177] In order to evaluate the feasibility of the ratio electrochemical sensor constructed by the present invention in actual samples and the accuracy of the method, this study used the spike recovery method to investigate it and used milk without kanamycin for detection.
[0178] First, the precipitate in the milk was separated by centrifugation, and then filtered using a 0.2 μm sterile Millipore membrane. Then, different concentrations of kanamycin were added to the filtered milk to obtain milk solutions with kanamycin concentrations of 10 pM, 1 nM, and 100 nM. The MB@SA-COF / BSA / Bio-Apt-TDN / AuNPs / Fe-CCOF / GCE electrode prepared in Example 1 was added to the milk solution and incubated at 37°C for 80 min. Then, a SWV test was performed in a PBS buffer (0.05 M, pH 7.0) containing 200 μM hydroquinone. The scan rate was 100 mV / s and the scan range was -0.6 V to 0.4 V. The signal ratio I was obtained. HQ / I MB The concentration of kanamycin in milk was calculated according to the standard linear equation, and the recovery rate was calculated. The determination was repeated three times in parallel. The recovery results of the three groups of spiked milk samples are shown in Table 1.
[0179] Recovery rate = actual Kana concentration in the sample / standard Kana concentration added to milk × 100%
[0180] The results show that the recovery rate is between 99.49% and 103.1%, and the RSD is between 1.2% and 3.0%, indicating that the sensor constructed by the present invention has a good recovery rate for detecting kanamycin in milk samples. Therefore, the constructed biosensor system is expected to be used as a reliable analytical method for rapid and sensitive detection of kanamycin residues in animal food.
[0181] Table 1 Recovery of kanamycin spiked in milk samples
[0182]
[0183]
[0184] In summary, the present invention constructs a ratio electrochemical biosensor based on a new Fe-CCOF nanomaterial, and uses the oxidation peak current generated by the Fe-CCOF nanomaterial catalytic oxidation of hydroquinone (HQ) and methylene blue (MB) in the MB@SA-COF bioconjugate to construct an electrochemical sensing system to achieve quantitative detection of kanamycin. The linear range of the sensor is 1pM to 1μM, the detection limit is 0.4pM, and it has high sensitivity and a wide linear range. The high sensitivity detection of kanamycin is mainly due to the excellent conductivity of the Fe-CCOF nanomaterial, and the ability to catalyze HQ to produce a higher oxidation peak current, which together with the oxidation peak current of MB in the MB@SA-COF bioconjugate constitutes a ratio signal, thereby achieving signal amplification. In addition, due to the high specificity of the nucleic acid aptamer, the sensor exhibits good anti-interference ability. In addition, due to the adoption of a ratio strategy, the interference of the electrochemical biosensor's own system and background signals is greatly reduced, the reproducibility and stability of the sensor are further improved, and the quantitative detection of kanamycin is achieved in actual sample milk. The constructed ratio strategy platform provides new ideas and possibilities for detecting other antibiotics.
[0185] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A functionalized nucleic acid probe, characterized in that: It includes a nucleic acid functionalized Fe-CCOF material and a signal-labeled COF material specifically bound to the nucleic acid functionalized Fe-CCOF material through streptavidin-biotin; The nucleic acid functionalized Fe-CCOF material comprises a Fe-CCOF material and a nucleic acid complex chemically bonded to the surface of the Fe-CCOF material through an Au-S bond; the nucleic acid complex comprises a DNA tetrahedron and a biotin-modified nucleic acid aptamer connected to a vertex of the DNA tetrahedron and matching the object to be detected; The signal-labeled COF material comprises a COF material, methylene blue loaded on the surface of the COF material, and streptavidin chemically bonded to the surface of the COF material through an amide bond; The Fe-CCOF material is prepared by carbonizing an amino-containing monomer, an aldehyde-containing monomer, and a monomer containing Fe and an aldehyde group through a condensation reaction.
2. The functionalized nucleic acid probe according to claim 1, characterized in that The DNA tetrahedron includes four DNA chains A, B, C and D, and the nucleotide sequences thereof are shown in SEQ ID NO.1 to SEQ ID NO.4 respectively. The nucleotide sequence of the biotin-modified nucleic acid aptamer is shown in SEQ ID NO.
5.
3. The functionalized nucleic acid probe according to claim 1, characterized in that The preparation method of the Fe-CCOF material comprises the following steps: The amino-containing monomer, the aldehyde-containing monomer, the Fe- and aldehyde-containing monomer, acetic acid and an organic solvent are uniformly mixed and subjected to a condensation reaction to obtain a Fe-COF material; Under an inert atmosphere, the Fe-COF material is carbonized to obtain a Fe-CCOF material.
4. The functionalized nucleic acid probe according to claim 3, characterized in that The amino group-containing monomer is 1,3,5-tris(4-aminophenyl)benzene, the aldehyde group-containing monomer is trimesic acid aldehyde, and the Fe and aldehyde group-containing monomer is ferrocene carboxaldehyde; and / or The condensation reaction temperature is 20°C to 40°C, and the condensation reaction time is 12h to 24h; and / or The carbonization temperature is 800° C. to 900° C., and the carbonization time is 3 h to 5 h.
5. The functionalized nucleic acid probe according to claim 1, characterized in that The COF material is prepared by using 2,5-dimethoxyterephthalaldehyde and 1,3,5-tris(4-aminophenyl)benzene as raw materials through a condensation reaction.
6. The functionalized nucleic acid probe according to claim 5, characterized in that The method for preparing the signal marking COF material comprises the following steps: 2,5-dimethoxyterephthalaldehyde and 1,3,5-tri(4-aminophenyl)benzene are added to the mixed organic solution, dispersed evenly, and acetic acid is added to carry out a condensation reaction to obtain a COF material; The COF material and the carboxyl-containing organic acid salt are added to water and mixed evenly to obtain a carboxylated COF dispersion; an organic amine is added to the carboxylated COF dispersion and mixed evenly, streptavidin is added, reacted, solid-liquid separated, washed, and the obtained solid is added to a methylene blue solution for adsorption to obtain a signal-labeled COF material.
7. Use of the functionalized nucleic acid probe according to any one of claims 1 to 6 in the preparation of an electrochemical biosensor for detecting kanamycin.
8. An electrochemical biosensor for detecting kanamycin, characterized in that: It comprises a glassy carbon electrode and the functionalized nucleic acid probe according to any one of claims 1 to 6 loaded on the glassy carbon electrode.
9. A method for preparing a biosensor for detecting kanamycin, characterized in that: The steps include: S1, preparation of nucleic acid functionalized Fe-CCOF material: S101, using an amino-containing monomer, an aldehyde-containing monomer, and a monomer containing Fe and an aldehyde group as raw materials, subjecting the monomer to condensation reaction and carbonization to obtain a Fe-CCOF material; The DNA tetrahedron and the biotin-modified nucleic acid aptamer are mixed and incubated to obtain a nucleic acid complex; S102, adding the Fe-CCOF material into water, dispersing it evenly, applying the obtained dispersion droplets onto the surface of the glassy carbon electrode, and drying it to obtain Fe-CCOF / GCE; S103, adding the Fe-CCOF / GCE into a chloroauric acid solution, and performing electrodeposition to obtain Au / Fe-CCOF / GCE; S104, drop-coating the nucleic acid complex onto the surface of the Au / Fe-CCOF / GCE, and incubating to obtain nucleic acid-functionalized Fe-CCOF material / GCE; S2, preparation of signal-labeled COF materials: S201, using 2,5-dimethoxyterephthalaldehyde and 1,3,5-tris(4-aminophenyl)benzene as raw materials, performing a condensation reaction to obtain a COF material; S202, adding the COF material and the carboxyl-containing organic acid salt into water, mixing them evenly, and obtaining a carboxylated COF dispersion; adding an organic amine into the carboxylated COF dispersion, mixing them evenly, adding streptavidin, reacting, solid-liquid separation, washing, and adding the obtained solid into a methylene blue solution for adsorption, and obtaining a signal-labeled COF material; S3, Preparation of electrochemical biosensor: The signal-labeled COF material is added to a buffer solution and dispersed evenly, and the dispersed liquid is dropwise coated on the surface of the nucleic acid-functionalized Fe-CCOF material / GCE, incubated, and dried to obtain an electrochemical biosensor for detecting kanamycin.
10. A method for detecting kanamycin, characterized in that: The following steps are involved: Step a, adding the biosensor for detecting kanamycin according to claim 8 or the biosensor for detecting kanamycin prepared according to claim 9 to a kanamycin standard solution of different concentrations for incubation, adding the incubated biosensor to a PBS buffer containing hydroquinone for square wave voltammetry test, and obtaining the oxidation peak current I of hydroquinone from the square wave voltammetry curve HQ and the oxidation peak current I of methylene blue MB , with I HQ / I MB The standard curve was drawn with as the ordinate and the concentration of kanamycin as the abscissa to obtain the linear equation; Step b, adding the biosensor to the solution to be tested, incubating, and performing a square wave voltammetry test on the incubated biosensor in a PBS buffer containing hydroquinone to obtain I HQ / I MB , the concentration of kanamycin in the test solution was obtained according to the linear equation.
Citation Information
Cited By
Inverted TDN modified electrode, CRISPR / Cas12a mediated DNA tetrahedral reporter probe interface cleavage ratio type electrochemical aptamer sensor and application
CN120275470A
Biosensor based on chitin membrane, preparation method and kit
CN120668752A
